Introduction
Clinical diagnosis of MI
Type 1 | Acute atherothrombotic occlusion or mural thrombus with critical flow reduction initiated by plaque rupture or erosion |
Type 2 | Ischemic injury due to a myocardial oxygen supply-demand mismatch, which is not caused by coronary atherothrombosis (Table 2) |
Type 3 | Cardiac death in a clinical setting suggestive of ischemic injury (chest pain, ECG changes) but without definitive cardiac biomarker evidence |
Type 4 | PCI-related ischemic injury < 48 h after procedure. Includes also cases of MI due to late stent thrombosis or restenosis |
Type 5 | CABG-related ischemic injury < 48 h after the procedure |
Fixed coronary atherosclerotic plaques | In combination with non-coronary causes of oxygen demand-supply imbalance |
Non-atherosclerotic coronary artery disease | Spasm/SVD, vasculitis, dissection, embolism, congenital anomalies, fibromuscular dysplasia, iatrogenic (stent or graft restenosis), PCI-related no-reflow |
Non-coronary cardiac oxygen demand-supply imbalance | Sustained tachyarrhythmias, bradyarrhythmias, LV hypertrophy and/or dilatation |
Extra cardiac oxygen demand-supply imbalance | Respiratory failure, severe anaemia, hypovolemic shock |
Ischemia and other forms of myocardial injury
Myocarditis | Toxic, immune mediated, infectious |
Cardiomyopathies | Adrenergic, RAAS, cytokine and mechanical stress |
Radiation-induced injury | Various mechanisms of myocardial cell death |
Drugs | May cause ischemic injury or other types of injury |
Endogenous catecholamines | Takotsubo, stress, extreme exercise |
Cardiac interventions | Cardiac surgery, PCI, TAVI, ablation procedures |
Trauma | Cardiac contusion, CPR-related tissue damage |
Sepsis | Extreme cytokine release |
Cerebrovascular accidents | Catecholamines and (neuro)inflammatory response |
Chronic kidney disease | Mechanical stress, toxic uraemic |
After cardiac transplantation | Myocardial immune injury (cellular and humoral rejection) |
Anatomical substrates of myocardial infarction at autopsy
Coronary artery pathology
Acute obstruction and critical stenosis
Stenosis due to stable (not thrombosed) plaques
Coronary spasm
Small vessel diseases
Iatrogenic pathology of the coronary arteries
Myocardial pathology in relation to ischemic death
Evolution of myocardial necrosis in prolonged ischemic conditions
Topographic distribution of MI in the heart
Post-mortem diagnosis of MI: gross, enzymatic and (immune) histological changes
Myocardial histologic parameters (HE staining) | Earliest manifestation | Full development | Decrease/disappearance |
---|---|---|---|
Streched/wavy fibres | 1–2 h | ||
Coagulative necrosis: ‘hypereosinophilia’ | 1–3 h | 1–3 days; hyper-eosinophilia and loss of striations | > 3 days: disintegration |
Interstitial oedema | 4–12 h | ||
Coagulative necrosis: ‘nuclear changes’ | 12–24 (pyknosis, karyorrhexis) | 1–3 days (loss of nuclei) | Depends on size of infarction |
PMN infiltration | 12–24 h | 1–3 days | 5–7 days |
PMN karyorrhexis | 1.5–2 days | 3–5 days | |
Macrophages and lymphocytes | 3–5 days | 5–10 days (including ‘siderophages’) | 10 days to 2 months |
Vessel/endothelial sprouts* | 5–10 days | 10 days–4 weeks | 4 weeks: disappearance of capillaries; some large dilated vessels persist |
Fibroblast and young collagen* | 5–10 days | 2–4 weeks | After 4 weeks; depends on size of infarction; |
Dense fibrosis | 4 weeks | 2–3 months | No |
Diagnostic method | Finding | Possible pitfalls |
---|---|---|
Histological examination | Contraction bands | Marker for ischemia/reperfusion (including border zones of ischemic infarctions), and other types of myocardial injury |
Histopathological timing of ischemia/infarction | Evolution may be affected by several variables (individual heterogeneity in the response to injury, repair and inflammatory response, size of infarction and medications that affect inflammation and wound healing, collateral circulation) Resuscitation trauma and autolysis can mimic histologic features of early MI (false positivity). | |
Immunohistochemistry | Some antibodies may have low sensitivity/specificity for early ischemic necrosis | Stains also other forms of myocardial injury; influenced by autolysis and post-mortem interval; probably early detection, but exact time of onset of immunopositivity not exactly known Can occur in cases with long post-mortem interval |
Nitro blue tetrazolium (NBT) staining | Diffuse or spotty discoloration | Unstained areas can occur in cases of long post-mortem interval, resuscitation attempts, sepsis, technical failures (see text) |
Post-mortem imaging | Calcifications in PMCT | Heavily calcified coronaries can be observed in stable plaques, not necessarily related to acute coronary syndromes and MI Non-calcified coronaries or spotty calcifications of coronaries might be observed in eroded plaques |
Perfusion of coronaries in PMCTA | Difficult to discriminate thrombus from post-mortem clot Some thrombosed coronary arteries (eroded plaques) might be perfused (mural thrombi) Difficult to evaluate the perfusion of heavily calcified coronaries | |
Interstitial oedema in PMMR | Also positive in other forms of injury, including CPR, and may occur as post-mortem alteration | |
Increased enhancement in PMCTA | Can be influenced by resuscitation and post-mortem alteration | |
Cardiac biomarkers | Increased of hs-TnT in serum | Serum value can be influenced by post-mortem alteration Cut-off of vital myocardial injury unknown |